Posts in category Columns

What might happen if supermarkets enter the pharmacy industry? asks Michael Rhodes Much debate has arisen about what happens next in the pharmacy industry and …

This week’s contributor wanted to remain anonymous: here, our Guest Author asks whether the Clinical Intervention scheme should exist in its current form at all …

Debbie Rigby examines the latest in research news  Management of hypertension in an Australian community pharmacy setting – patients’ beliefs and perspectives This article reports …

Here is a list of ways the Pharmacy Guild has worked on the codeine issue, explains Executive Director David Quilty Dear AJP readers I must …

Mark Blundell and Shannon Davies take a look at legislated protections for pharmacist tenants In what are challenging economic times, the article published here recently …

Failure to lift the cap on HMRs makes no sense, writes Karalyn Huxhagen The recent discussion about the new Community Pharmacy Agreement rules has fuelled …

Debbie Rigby takes a look at the latest in research news Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in …

What makes a pharmacy attractive to buyers, asks Natalie Sirianni of Attain Business Brokers? The pharmacy market is currently very active with the number of pharmacy …

Evidence-based screening, as well as medication management, is an area where pharmacists have a vital role to play says PSA national president Shane Jackson  The …

The profession must engage in broader health care and social debates, writes AJP Editor Chris Brooker While pharmacy as a profession strives to expand its …